Latest Valence8 US LP Stock Portfolio
Valence8 US LP Performance:
2024 Q4: 0.42%YTD: 5.13%2023: 6.17%
Performance for 2024 Q4 is 0.42%, and YTD is 5.13%, and 2023 is 6.17%.
About Valence8 US LP and 13F Hedge Fund Stock Holdings
Valence8 US LP is a hedge fund based in CAMBRIDGE, MA. On 18-Sep-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $574.6 Millions. In it's latest 13F Holdings report, Valence8 US LP reported an equity portfolio of $208.2 Millions as of 31 Dec, 2024.
The top stock holdings of Valence8 US LP are IBCE, QQQ, ACWF. The fund has invested 28% of it's portfolio in ISHARES TR and 20.6% of portfolio in INVESCO QQQ TR.
The fund managers got completely rid off JAZZ PHARMACEUTICALS PLC (JAZZ), BRISTOL-MYERS SQUIBB CO (BMY) and ASCENDIS PHARMA A/S stocks. They significantly reduced their stock positions in ISHARES INC (EMGF), ISHARES TR (AGT) and INVESCO QQQ TR (QQQ). Valence8 US LP opened new stock positions in ISHARES TR (IJR). The fund showed a lot of confidence in some stocks as they added substantially to ISHARES TR (AAXJ), VANGUARD INDEX FDS (VB) and SELECT SECTOR SPDR TR (XLB).
The top stock holdings of Valence8 US LP are IBCE, QQQ, ACWF. The fund has invested 28% of it's portfolio in ISHARES TR and 20.6% of portfolio in INVESCO QQQ TR.
The fund managers got completely rid off JAZZ PHARMACEUTICALS PLC (JAZZ), BRISTOL-MYERS SQUIBB CO (BMY) and ASCENDIS PHARMA A/S stocks. They significantly reduced their stock positions in ISHARES INC (EMGF), ISHARES TR (AGT) and INVESCO QQQ TR (QQQ). Valence8 US LP opened new stock positions in ISHARES TR (IJR). The fund showed a lot of confidence in some stocks as they added substantially to ISHARES TR (AAXJ), VANGUARD INDEX FDS (VB) and SELECT SECTOR SPDR TR (XLB).
Valence8 US LP Annual Return Estimates Vs S&P 500
Our best estimate is that Valence8 US LP made a return of 0.42% in the last quarter. In trailing 12 months, it's portfolio return was 5.13%.
New Buys
| Ticker | $ Bought |
|---|---|
| ishares tr | 7,800,250 |
New stocks bought by Valence8 US LP
Additions
| Ticker | % Inc. |
|---|---|
| ishares tr | 1.27 |
| vanguard index fds | 0.79 |
| select sector spdr tr | 0.59 |
| select sector spdr tr | 0.54 |
Additions to existing portfolio by Valence8 US LP
Reductions
| Ticker | % Reduced |
|---|---|
| ishares inc | -46.01 |
| ishares tr | -44.26 |
| invesco qqq tr | -4.94 |
| ishares tr | -3.49 |
| ishares tr | -3.13 |
Valence8 US LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| indivior plc | -564,186 |
| erasca inc | -128,100 |
| vistagen therapeutics inc | -103,472 |
| vir biotechnology inc | -252,039 |
| relay therapeutics inc | -185,496 |
| nektar therapeutics | -33,939 |
| zevra therapeutics inc | -149,876 |
| enanta pharmaceuticals inc | -206,568 |
Valence8 US LP got rid off the above stocks
Sector Distribution
Valence8 US LP has about 100% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 100 |
Market Cap. Distribution
Valence8 US LP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 100 |
Stocks belong to which Index?
About 0% of the stocks held by Valence8 US LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 100 |
| Top 5 Winners (%) | % | |
|---|---|---|
| QQQ | 4.7 % | |
| Top 5 Winners ($) | $ | |
|---|---|---|
| QQQ | 2.0 M | |
| Top 5 Losers (%) | % | |
|---|---|---|
| XLB | -6.3 % | |
| XLB | -5.3 % | |
| IJR | -0.9 % | |
| Top 5 Losers ($) | $ | |
|---|---|---|
| XLB | -0.7 M | |
| XLB | -0.3 M | |
| IJR | -0.1 M | |
Valence8 US LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Valence8 US LP
Valence8 US LP has 10 stocks in it's portfolio. XLB proved to be the most loss making stock for the portfolio. QQQ was the most profitable stock for Valence8 US LP last quarter.
Last Reported on: 12 Feb, 2025| Ticker | Namesorted descending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| IBCE | ishares tr | 27.96 | 326,910 | 58,216,100 | reduced | -3.13 | ||
Historical Trend of ISHARES TR Position Held By Valence8 US LPWhat % of Portfolio is IBCE?:Number of IBCE shares held:Change in No. of Shares Held: | ||||||||
| QQQ | invesco qqq tr | 20.57 | 83,798 | 42,840,100 | reduced | -4.94 | ||
| ACWF | ishares tr | 17.66 | 990,439 | 36,765,100 | reduced | -3.49 | ||
| AAXJ | ishares tr | 10.19 | 404,248 | 21,210,900 | added | 1.27 | ||
| VB | vanguard index fds | 7.92 | 97,398 | 16,489,500 | added | 0.79 | ||
| XLB | select sector spdr tr | 6.27 | 166,161 | 13,061,900 | added | 0.54 | ||
| IJR | ishares tr | 3.75 | 77,909 | 7,800,250 | new | |||
| AGT | ishares tr | 1.90 | 116,688 | 3,955,720 | reduced | -44.26 | ||
| XLB | select sector spdr tr | 1.90 | 52,247 | 3,954,580 | added | 0.59 | ||
| EMGF | ishares inc | 1.89 | 58,649 | 3,935,350 | reduced | -46.01 | ||
| CRNX | crinetics pharmaceuticals in | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ELYM | eliem therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ENTA | enanta pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ERAS | erasca inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| NTLA | intellia therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALEC | alector inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BMY | bristol-myers squibb co | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BPMC | blueprint medicines corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ascendis pharma a/s | 0.00 | 0.00 | 0.00 | sold off | -100 | |||
| argenx se | 0.00 | 0.00 | 0.00 | sold off | -100 | |||
